Study of SGN1 in Patients With Advanced Solid Tumor

NCT05038150 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: SGN1

Sponsor

Guangzhou Sinogen Pharmaceutical Co., Ltd